DM Programs Can Fill 'Gap' Left by Suboptimal Rx Treatment
Disease management (DM) programs incorporating pharmaceuticals can lower overall health care costs for payers by helping fill in the "treatment gap" that often results in suboptimal or interrupted drug therapy, according to industry insiders and health plans that have implemented such initiatives. And a related strategy of lowering drug copayments in exchange for patient participation in DM programs has proven to be well worth the investment for some payers.To read this article in its entirety click on Disease Management.


0 Comments:
Post a Comment
<< Home